DexCom PE Ratio 2010-2024 | DXCM
Current and historical p/e ratio for DexCom (DXCM) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. DexCom PE ratio as of October 25, 2024 is 43.20.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
DexCom PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-10-24 | 74.85 | 46.20 | |
2024-06-30 | 113.38 | $1.62 | 69.99 |
2024-03-31 | 138.70 | $1.55 | 89.48 |
2023-12-31 | 124.09 | $1.31 | 94.73 |
2023-09-30 | 93.30 | $0.91 | 102.53 |
2023-06-30 | 128.51 | $0.86 | 149.43 |
2023-03-31 | 116.18 | $0.70 | 165.97 |
2022-12-31 | 113.24 | $0.81 | 139.37 |
2022-09-30 | 80.54 | $0.54 | 148.46 |
2022-06-30 | 74.53 | $0.48 | 155.27 |
2022-03-31 | 127.90 | $0.52 | 247.15 |
2021-12-31 | 134.24 | $0.39 | 346.42 |
2021-09-30 | 136.72 | $1.31 | 104.56 |
2021-06-30 | 106.75 | $1.31 | 81.33 |
2021-03-31 | 89.85 | $1.28 | 70.47 |
2020-12-31 | 92.43 | $1.23 | 75.45 |
2020-09-30 | 103.06 | $0.61 | 170.34 |
2020-06-30 | 101.35 | $0.55 | 185.11 |
2020-03-31 | 67.32 | $0.40 | 169.35 |
2019-12-31 | 54.69 | $0.27 | 202.54 |
2019-09-30 | 37.31 | $-0.49 | 0.00 |
2019-06-30 | 37.46 | $-0.48 | 0.00 |
2019-03-31 | 29.78 | $-0.37 | 0.00 |
2018-12-31 | 29.95 | $-0.36 | 0.00 |
2018-09-30 | 35.76 | $0.12 | 304.34 |
2018-06-30 | 23.75 | $-0.02 | 0.00 |
2018-03-31 | 18.54 | $-0.10 | 0.00 |
2017-12-31 | 14.35 | $-0.15 | 0.00 |
2017-09-30 | 12.23 | $-0.14 | 0.00 |
2017-06-30 | 18.29 | $-0.19 | 0.00 |
2017-03-31 | 21.18 | $-0.26 | 0.00 |
2016-12-31 | 14.93 | $-0.20 | 0.00 |
2016-09-30 | 21.92 | $-0.17 | 0.00 |
2016-06-30 | 19.83 | $-0.25 | 0.00 |
2016-03-31 | 16.98 | $-0.20 | 0.00 |
2015-12-31 | 20.48 | $-0.18 | 0.00 |
2015-09-30 | 21.47 | $-0.18 | 0.00 |
2015-06-30 | 20.00 | $-0.07 | 0.00 |
2015-03-31 | 15.59 | $-0.08 | 0.00 |
2014-12-31 | 13.76 | $-0.08 | 0.00 |
2014-09-30 | 10.00 | $-0.10 | 0.00 |
2014-06-30 | 9.92 | $-0.10 | 0.00 |
2014-03-31 | 10.34 | $-0.11 | 0.00 |
2013-12-31 | 8.85 | $-0.11 | 0.00 |
2013-09-30 | 7.06 | $-0.13 | 0.00 |
2013-06-30 | 5.61 | $-0.17 | 0.00 |
2013-03-31 | 4.18 | $-0.19 | 0.00 |
2012-12-31 | 3.40 | $-0.20 | 0.00 |
2012-09-30 | 3.76 | $-0.21 | 0.00 |
2012-06-30 | 3.24 | $-0.20 | 0.00 |
2012-03-31 | 2.61 | $-0.18 | 0.00 |
2011-12-31 | 2.33 | $-0.17 | 0.00 |
2011-09-30 | 3.00 | $-0.17 | 0.00 |
2011-06-30 | 3.62 | $-0.17 | 0.00 |
2011-03-31 | 3.88 | $-0.20 | 0.00 |
2010-12-31 | 3.41 | $-0.25 | 0.00 |
2010-09-30 | 3.31 | $-0.27 | 0.00 |
2010-06-30 | 2.89 | $-0.29 | 0.00 |
2010-03-31 | 2.44 | $-0.32 | 0.00 |
2009-12-31 | 2.02 | $-0.30 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $29.429B | $3.622B |
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $211.771B | 25.38 |
Intuitive Surgical (ISRG) | United States | $182.104B | 95.21 |
Alcon (ALC) | Switzerland | $46.488B | 32.73 |
Edwards Lifesciences (EW) | United States | $41.795B | 25.99 |
IQVIA Holdings (IQV) | United States | $39.127B | 22.17 |
IDEXX Laboratories (IDXX) | United States | $37.154B | 44.69 |
STERIS (STE) | Ireland | $22.102B | 25.79 |
SONOVA HOLDING (SONVY) | Switzerland | $21.443B | 0.00 |
Waters (WAT) | United States | $19.266B | 28.72 |
Hologic (HOLX) | United States | $18.775B | 20.41 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.282B | 13.77 |
Sysmex ADR (SSMXY) | Japan | $11.618B | 36.43 |
Teleflex (TFX) | United States | $11.008B | 17.12 |
Globus Medical (GMED) | United States | $9.908B | 27.72 |
Penumbra (PEN) | United States | $7.952B | 82.54 |
Masimo (MASI) | United States | $7.412B | 39.70 |
Glaukos (GKOS) | United States | $7.176B | 0.00 |
Integer Holdings (ITGR) | United States | $4.217B | 23.91 |
TransMedics (TMDX) | United States | $4.176B | 178.81 |
PROCEPT BioRobotics (PRCT) | United States | $3.571B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.878B | 16.88 |
Inari Medical (NARI) | United States | $2.546B | 0.00 |
Veracyte (VCYT) | United States | $2.537B | 157.29 |
Nihon Kohden (NHNKY) | Japan | $2.481B | 15.44 |
Elekta AB (EKTAY) | Sweden | $2.456B | 20.01 |
Tandem Diabetes Care (TNDM) | United States | $2.052B | 0.00 |
RxSight (RXST) | United States | $1.863B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.470B | 6.70 |
Artivion (AORT) | United States | $1.109B | 101.81 |
Pulse Biosciences (PLSE) | United States | $1.080B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.027B | 18.31 |
OPKO Health (OPK) | United States | $0.990B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.737B | 0.00 |
IRadimed (IRMD) | United States | $0.638B | 34.51 |
OrthoPediatrics (KIDS) | United States | $0.622B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.611B | 15.44 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.606B | 0.00 |
AxoGen (AXGN) | United States | $0.583B | 0.00 |
SiBone (SIBN) | United States | $0.528B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.482B | 0.00 |
Paragon 28 (FNA) | United States | $0.409B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.360B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.337B | 10.29 |
Delcath Systems (DCTH) | United States | $0.297B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.292B | 0.00 |
AngioDynamics (ANGO) | United States | $0.273B | 0.00 |
Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
CVRx (CVRX) | United States | $0.219B | 0.00 |
Inogen (INGN) | United States | $0.219B | 0.00 |
Semler Scientific (SMLR) | United States | $0.192B | 13.44 |
NeuroPace (NPCE) | United States | $0.185B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
Accuray (ARAY) | United States | $0.175B | 0.00 |
Nevro (NVRO) | United States | $0.171B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.153B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
908 Devices (MASS) | United States | $0.114B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.104B | 15.54 |
EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.093B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.078B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
LENSAR (LNSR) | United States | $0.062B | 0.00 |
InspireMD (NSPR) | Israel | $0.061B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.049B | 0.00 |
Envoy Medical (COCH) | United States | $0.048B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
Neuronetics (STIM) | United States | $0.030B | 0.00 |
DarioHealth (DRIO) | United States | $0.029B | 0.00 |
Precision Optics (POCI) | United States | $0.025B | 0.00 |
Spectral AI (MDAI) | United States | $0.024B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
NexGel (NXGL) | United States | $0.019B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.019B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.016B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.009B | 0.00 |
Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |